ENDURX PHARMACEUTICALS
USPTO Trademark Record · Serial No. 86030250
Trademark details
It was initially claimed by EnduRx Pharmaceuticals, Inc. on 20130806.
That brand applies to the following goods and services:Research and development in the field of cancer therapeutics, cardiovascular therapeutics, oncology, cardiovascular disease, nanoparticles, and targeted therapies; Pharmaceutical services, namely, developing tumor and cardiovascular targeting platform technologies, Providing therapeutic treatments and diagnostic imaging agents for cancer and vascular disease.
Currently that trademark is represented by trademark attorney(s): Christopher P. Perkins, Ph.D..
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the ENDURX PHARMACEUTICALS trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
